Lucrèce Foufopoulos-De Ridder
About Lucrèce Foufopoulos-De Ridder
Independent non‑employee director of Tronox Holdings plc (TROX), age 56 as of March 15, 2025; joined the Board in May 2024. Former Executive Vice President at Borealis Group overseeing Polyolefins, Circular Economy Solutions, and Innovation & Technology (2019–2023), with prior senior roles at Eastman Chemical, Dow Chemical, Rohm and Haas, Dow Corning, and Raychem. Brings deep chemicals industry expertise and sustainability/circular economy credentials; currently serves on several global public company boards with committee leadership responsibilities.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Borealis Group | Executive Vice President, Polyolefins, Circular Economy Solutions, Innovation & Technology | Jan 2019 – Dec 2023 | Led technology and sustainability initiatives; global executive leadership in chemicals |
| Eastman Chemical Company | VP & GM, Rubber Additives; Chief Commercial Officer | 2014 – 2018 | Commercial and P&L leadership in additives; strategic growth |
| Dow Chemical; Rohm and Haas; Dow Corning; Raychem | Various business, strategy, commercial and technology leadership roles | Not disclosed | Broad chemicals and materials leadership across global platforms |
External Roles
| Organization | Exchange/Ticker | Role | Committees/Chair |
|---|---|---|---|
| Amcor PLC | NYSE: AMCR | Director | Compensation Committee member |
| Sika AG | SIX: SIKA | Director | Chair, Sustainability Committee |
| Royal Vopak N.V. | Euronext: VPK | Director | Audit Committee; Remuneration Committee member |
| Quaker Houghton | NYSE: KWS | Director | Compensation & HR Committee; Sustainability Committee member |
Board Governance
- Independence: Classified as independent under NYSE listing standards; Board has majority independent directors and fully independent committees.
- Committee Assignments (TROX): Member, Corporate Governance and Sustainability Committee. Not currently on Audit or HRCC.
- Attendance/Engagement: 100% attendance at Board and committee meetings in 2024; Board held 5 meetings and 4 executive sessions.
- Diversity & Refresh: Appointed in 2024 as part of Board’s gender diversity objective; Board targeted ~30% female representation by 2025 AGM.
- Over‑boarding Policy: Limit of five public company boards; all current directors in compliance (she holds multiple boards but within limit).
Fixed Compensation
| Year | Cash Retainer and Fees (USD) | Committee Chair/Member Fees (USD) | Total Cash (USD) |
|---|---|---|---|
| 2024 | $74,560 | Included within cash total; CG&S committee member retainer policy $15,000 per committee member annually (aggregated in cash figure; pro‑rated as she joined May 8, 2024) | $74,560 |
Notes:
- Standard non‑employee director cash retainer $100,000 annually; committee member retainer $15,000; Audit Chair $50,000; HRCC Chair $20,000; CG&S Chair $20,000. She is not a chair.
- UK tax equalization/payments: None recorded for her in 2024 (no UK tax prep, reimbursements, or equalization payments).
Performance Compensation
| Year | Grant Type | Grant Date | Number of RSUs | Grant Value Basis | Accounting Fair Value (USD) | Vesting Schedule | Dividend Equivalents |
|---|---|---|---|---|---|---|---|
| 2024 | Time‑based RSUs | May 8, 2024 | 8,324 | $150,000 grant value set using 10‑day avg price $18.02 | $159,738 (valued at $19.19 closing price on grant date) | Vests at earlier of next AGM or May 31 of following year (subject to continued Board service) | Accrue and pay upon vesting |
Notes:
- TROX director equity is time‑based; no performance‑conditioned PSUs or options are used for directors.
- All non‑employee directors received identical RSU grants and vesting terms at the 2024 AGM.
Other Directorships & Interlocks
| Company | Potential Overlap with TROX | Disclosed Related‑Party Exposure |
|---|---|---|
| Amcor PLC | Packaging end‑markets may use pigments; no specific transactions disclosed | None disclosed for her; Company maintains a Related Party Transactions Policy |
| Sika AG | Building materials/chemicals potentially adjacent to TiO2 applications | None disclosed for her |
| Royal Vopak N.V. | Storage/terminals infrastructure; potentially adjacent to chemical logistics | None disclosed for her |
| Quaker Houghton | Industrial process fluids; indirect adjacency | None disclosed for her |
Expertise & Qualifications
- Chemicals industry senior leadership with innovation and sustainability orientation; brings global business experience and risk management perspective.
- Board skills matrix emphasizes finance, risk, logistics/supply chain across nominees; she is cited for chemicals and sustainability expertise in her bio.
- Governance depth through CG&S committee membership overseeing sustainability targets, policies, and director remuneration.
Equity Ownership
| Holder | Shares Beneficially Owned | % of Shares Outstanding | Composition |
|---|---|---|---|
| Lucrèce Foufopoulos-De Ridder | 8,324 | <1% (*) | Includes RSUs scheduled to vest within 60 days of March 10, 2025 (aligned with AGM vesting) |
Ownership alignment policies:
- Director Stock Ownership Guideline: 500% of annual cash retainer; 5‑year compliance window; time‑based RSUs count 60% toward guidelines; performance‑based RSUs do not.
- Compliance Status: Not yet met due to recent appointment; within allowed 5‑year period.
- Anti‑hedging/derivatives and short‑sales prohibited; corporate clawback policy adopted (executive‑focused).
Governance Assessment
-
Positive signals:
- Independent director with deep chemicals and sustainability credentials; sits on CG&S committee, aligning board oversight with ESG strategy and targets.
- 100% attendance in 2024; demonstrates engagement; Board held executive sessions to review management performance.
- Equity‑heavy director pay (time‑based RSUs) and robust ownership guidelines support alignment; anti‑hedging policy enhances investor confidence.
- Strong say‑on‑pay outcomes (97% approval in 2024; ≥96% for last 6 years) signal broad shareholder support for compensation governance.
-
Watch items / potential red flags:
- Multiple external public boards (Amcor, Sika, Vopak, Quaker Houghton) imply significant time commitments; however she remains within TROX’s five‑board limit and is in compliance per policy.
- Ownership currently small (<1%) given recent appointment; expected to increase as RSUs vest and guidelines phase in over 5 years.
- Board includes two non‑independent directors nominated by largest shareholder Cristal Netherlands/Tasnee; while not specific to her, this shareholder representation can influence governance dynamics.
-
Related‑party risk:
- No related‑party transactions disclosed for her; Company’s Related Party Transactions Policy overseen by CG&S provides review/mitigation framework.
-
Committee effectiveness:
- CG&S actively oversees sustainability goals, community relations, and director remuneration; collaborates with HRCC on annual ESG targets in AIP, signaling integrated oversight.
Director Compensation Summary (2014–2024 focus year)
| Item | Amount (USD) | Notes |
|---|---|---|
| Fees earned/paid in cash (2024) | $74,560 | Pro‑rated; includes committee member retainer per policy |
| Stock awards (2024) | $159,738 | 8,324 RSUs; grant date May 8, 2024; valued at $19.19 close; grant value basis $150,000 from 10‑day avg price $18.02 |
| Total (2024) | $234,298 | Sum of cash and equity fair value |
| UK tax prep/reimbursement/equalization (2024) | $0 | No UK tax benefits recorded for her |
TROX ESG/Compensation Context (for pay‑for‑performance environment)
- Annual incentive plan includes safety (DIFR/TRIFR) and carbon intensity metrics alongside financial measures, with 20% of AIP tied to ESG (15% safety; 5% carbon), reinforcing board‑level ESG oversight.
Conclusion
Lucrèce Foufopoulos‑De Ridder enhances Board effectiveness through chemicals/sustainability expertise and CG&S committee work, with full attendance and independent status supporting investor confidence. Monitor time‑commitment risk from multiple external boards and progression toward ownership guideline compliance; no related‑party exposure disclosed for her, and alignment structures (RSUs, anti‑hedging, guidelines) are robust.